MicroRNA-146b inhibition augments hypoxia-induced cardiomyocyte apoptosis

Molecular Medicine Reports

Volumn 12, Issue 5, 2015, Pages 6903-6910

  Li, Jing Wei ^a   He, Si Yi ^a   Feng, Ze Zhou ^a   Zhao, Liang ^a   Jia, Wei Kun ^a   Liu, Peng ^a   Zhu, Yun ^a   Jian, Zhao ^a   Xiao, Ying Bin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Hypoxia; MicroRNA 146b; RNase L

Indexed keywords

CASPASE 3; HEMOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; MESSENGER RNA; MICRORNA; MICRORNA 146B; PROTEIN BAX; PROTEIN BCL 2; RIBONUCLEASE L; STAT3 PROTEIN; UNCLASSIFIED DRUG; MIRN146 MICRORNA, HUMAN; MIRN146 MICRORNA, RAT;

3' UNTRANSLATED REGION; AGE; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL HYPOXIA; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC TRANSFECTION; HEART EXCITATION; HEART MUSCLE CELL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFANT; MALE; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; OXYGEN SATURATION; POLYMERASE CHAIN REACTION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANOXIA; ANTAGONISTS AND INHIBITORS; CARDIAC MUSCLE CELL; CELL CULTURE; CELL LINE; COMPLICATION; CONGENITAL HEART MALFORMATION; CYTOLOGY; GENETICS; METABOLISM; PATHOLOGY; RAT;

ANIMALS; ANOXIA; APOPTOSIS; CELL HYPOXIA; CELL LINE; CELLS, CULTURED; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; MICRORNAS; MYOCYTES, CARDIAC; RATS; TRANSFECTION; UP-REGULATION;

EID: 84943596876     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4333     Document Type: Article

References (29)

1. Jian Z, Li JB, Ma RY, Chen L, Zhong QJ, Wang XF, Wang W, Hong Y and Xiao YB: Increase of macrophage migration inhibitory factor (MIF) expression in cardiomyocytes during chronic hypoxia. Clin Chim Acta 405: 132-138, 2009.
2. Waskova-Arnostova P, Kasparova D, Elsnicova B, Novotny J, Neckar J, Kolar F and Zurmanova J: Chronic hypoxia enhances expression and activity of mitochondrial creatine kinase and hexokinase in the rat ventricular myocardium. Cell Physiol Biochem: 33: 310-320, 2014.
3. Hausser J and Zavolan M: Identification and consequences of miRNA-target interactions-beyond repression of gene expression. Nat Rev Genet 15: 599-612, 2014.
4. Condorelli G, Latronico MV and Cavarretta E: microRNAs in cardiovascular diseases: Current knowledge and the road ahead. J Am Coll Cardiol 63: 2177-2187, 2014.
5. He S, Liu P, Jian Z, Li J, Zhu Y, Feng Z and Xiao Y: miR-138 protects cardiomyocytes from hypoxia-induced apoptosis via MLK3/JNK/c-jun pathway. Biochem Biophys Res Commun 441: 763-769, 2013.
6. Zhang J, Chang JJ, Xu F, Ma XJ, Wu Y, Li WC, Wang HJ, Huang GY and Ma D: MicroRNA deregulation in right ventricular outflow tract myocardium in nonsyndromic tetralogy of fallot. Can J Cardiol 29: 1695-1703, 2013.
7. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL and Loscalzo J: MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 10: 273-284, 2009.
8. Wang D, Liu YL, Lü XD, Ling F, Liu AJ, Du J and Han L: Lung microRNA profile in chronic cyanotic piglets with decreased pulmonary blood flow. Chin Med J (Engl) 126: 2260-2264, 2013.
9. Taganov KD, Boldin MP, Chang KJ and Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103: 12481-12486, 2006.
10. Curtale G, Mirolo M, Renzi TA, Rossato M, Bazzoni F and Locati M: Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b. Proc Natl Acad Sci USA 110: 11499-11504, 2013.
11. Xiang M, Birkbak NJ, Vafaizadeh V, Walker SR, Yeh JE, Liu S, Kroll Y, Boldin M, Taganov K, Groner B, et al: STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-kappaB to IL-6 signaling axis and STAT3-driven cancer phenotypes. Sci Signal 7: ra11, 2014.
12. Mehmet H and Edwards AD: Hypoxia, ischaemia, and apoptosis. Arch Dis Child Fetal Neonatal Ed 75: F73-F75, 1996.
13. Perry MM, Williams AE, Tsitsiou E, Larner-Svensson HM and Lindsay MA: Divergent intracellular pathways regulate interleukin-1beta-induced miR-146a and miR-146b expression and chemokine release in human alveolar epithelial cells. FEBS Lett 583: 3349-3355, 2009.
14. Hamid T, Gu Y, Ortines RV, Bhattacharya C, Wang G, Xuan YT and Prabhu SD: Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: Role of nuclear factor-kappaB and inflammatory activation. Circulation 119: 1386-1397, 2009.
15. Cheng HS, Sivachandran N, Lau A, Boudreau E, Zhao JL, Baltimore D, Delgado-Olguin P, Cybulsky MI and Fish JE: MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol Med 5: 949-966, 2013.
16. Wang H, Zuo X, Wang Q, Boudreau E, Zhao JL, Baltimore D, Delgado-Olguin P, Cybulsky MI and Fish JE: Nicorandil inhibits hypoxia-induced apoptosis in human pulmonary artery endothelial cells through activation of mitoKATP and regulation of eNOS and the NF-kappaB pathway. Int J Mol Med 32: 187-194, 2013.
17. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS and Welch DR: Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 69: 1279-1283, 2009.
18. Wang X, Ha T, Liu L, Zou J, Zhang X, Kalbfleisch J, Gao X, Williams D and Li C: Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. Cardiovasc Res 97: 432-442, 2013.
19. Halkein J, Tabruyn SP, Ricke-Hoch M, Haghikia A, Nguyen NQ, Scherr M, Castermans K, Malvaux L, Lambert V, Thiry M, et al: MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 123: 2143-2154, 2013.
20. Walker SR, Xiang M and Frank DA: STAT3 Activity and Function in Cancer: Modulation by STAT5 and miR-146b. Cancers (Basel) 6: 958-968, 2014.
21. Gu Q, Kong Y, Yu ZB, Bai L and Xiao YB: Hypoxia-induced SOCS3 is limiting STAT3 phosphorylation and NF-κB activation in congenital heart disease. Biochimie 93: 909-920, 2011.
22. Hilfiker-Kleiner D, Hilfiker A, Fuchs M, Kaminski K, Schaefer A, Schieffer B, Hillmer A, Schmiedl A, Ding Z, Podewski E, et al: Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 95: 187-195, 2004.
23. Domingo-Gil E and Esteban M: Role of mitochondria in apoptosis induced by the 2-5A system and mechanisms involved. Apoptosis 11: 725-738, 2006.
24. Malathi K, Paranjape JM, Ganapathi R and Silverman RH: HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2',5'-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 64: 9144-9151, 2004.
25. Chakrabarti A, Jha BK and Silverman RH: New insights into the role of RNase L in innate immunity. J Interferon Cytokine Res 31: 49-57, 2011.
26. Siddiqui WA, Ahad A and Ahsan H: The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update. Arch Toxicol 89: 289-317, 2015.
27. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE and Oltvai ZN: Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4: 327-332, 1993.
28. Shalini S, Dorstyn L, Dawar S and Kumar S: Old, new and emerging functions of caspases. Cell Death Differ 22: 526-539, 2015.
29. Li G, Xiang Y, Sabapathy K and Silverman RH: An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. J Biol Chem 279: 1123-1131, 2004.